ReviewAnnals of intensive care2026
The role of cytokines in septic myocardial dysfunction: a translational systematic review and meta-analysis.
Review in Annals of intensive care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Septic Cardiomyopathy in the ICU: Echocardiographic Phenotypes, Global Longitudinal Strain, and Right Ventricular Assessment.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Septic myocardial dysfunction is a frequent complication of sepsis, commonly defined by impaired cardiac contractility. Despite its clinical significance, its pathophysiology remains poorly understood and no targeted therapy is currently available. Pro-inflammatory cytokines have been implicated in experimental models, but their causal role and therapeutic relevance in septic myocardial dysfunction remain uncertain. We aimed to systematically review and meta-analyze the impact of cytokine addition or blockade on myocardial function in sepsis across in vitro, in vivo, and human studies. Methods: We performed a systematic search of MEDLINE, Embase, Cochrane, and PubMed databases up to December 2024. We included all cellular, animal, and human studies (descriptive or interventional) assessing the effect of cytokine modulation on myocardial contractility in sepsis. Studies lacking contractility assessment were excluded from the meta-analysis but retained in the systematic review. Standardized mean differences (SMDs) were pooled using a random-effects model. Risk of bias was assessed using dedicated tools adapted to each study design. Results: A total of 39 studies were included in the systematic review, and 21 in the meta-analysis. Eleven in vitro or ex vivo studies showed that cardiomyocyte contractility was significantly reduced after exposure to IL-1 (SMD 5.62 [5.01;6.23]), IL-6 (4.24 [1.49;6.99]) and TNF-α (4.45 [3.17;5.72]); all were included in the meta-analysis. Seventeen in vivo animal studies were reviewed, of which six were eligible for meta-analysis: TNF-α (5.06 [1.46;8.65]) and IL-18 (1.56 [0.77;2.36]) were associated with significant cardiac depression, whereas IL-1 showed a non-significant effect (2.58 [-0.90;6.07]). Among eleven human studies, four were included in the meta-analysis. Patients with septic myocardial dysfunction had higher circulating levels of IL-6 (SMD 0.51 [0.06;0.97]), IL-1 (0.67 [0.11;1.23]), IL-8 (0.59 [0.35;0.83]) and IL-10 (0.57 [0.34;0.80]) than controls, while the difference for TNF-α was not significant (0.63 [-0.02;1.28]). Two small interventional studies suggested potential benefits from cytokine-targeting therapies. Conclusions: This translational review supports a cytokine-mediated contribution to septic myocardial dysfunction. While mechanistic evidence is strong in preclinical models, clinical data remain observational. These findings justify further interventional studies targeting cytokines in septic myocardial dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.